Castle Creek Biosciences, Inc. of Exton, PA, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-24. The offering totals $560.5M, of which $560.5M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 28 people.
| Name | Role | Location |
|---|---|---|
| Timothy Cunniff | Director | Chicago, IL |
| Michael Derby | Director | Laval, A8 |
| Michael Derby | Executive Officer | Laval, A8 |
| Patrick Morris | Executive Officer | Chicago, IL |
| ANTONIO GRACIAS | Director | Hawthorne, CA |
| David Brill | Director | Exton, PA |
| Matthew Crabtree | Director | Exton, PA |
| Jeffrey Aronin | Director | Exton, PA |
| Matthew Gantz | Director | Exton, PA |
| Matthew Gantz | Executive Officer | Exton, PA |
| Patrick Morris | Director | Chicago, IL |
| Jude Sullivan | Executive Officer | Exton, PA |
| Darien Parhad | Executive Officer | Exton, PA |
| Timothy M Cunniff | Director | Chicago, IL |
| Patrick J Morris | Director | Chicago, IL |
| Patrick J Morris | Executive Officer | Chicago, IL |
| Jeffrey S Aronin | Director | Chicago, IL |
| Mark J Graf | Director | Exton, PA |
| Matthew J Gantz | Director | Exton, PA |
| Matthew J Gantz | Executive Officer | Exton, PA |
| W. Bradford Middlekauff | Executive Officer | Exton, PA |
| Mary Bradford Spellman | Executive Officer | Exton, PA |
| Babar J Ghias | Executive Officer | Exton, PA |
| Gregory J MacMichael | Executive Officer | Exton, PA |
| Gregory Bradford Wujek | Executive Officer | Exton, PA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-02-25 | D | $75.0M | $75.0M |
| 2022-05-02 | D | $112.8M | $112.8M |
| 2022-02-03 | D | $11.8M | $11.8M |
| 2021-07-09 | D | $25.0M | $25.0M |
| 2020-01-21 | D | $54.6M | $54.6M |